U.S. Antimony details pricing of direct offering

United States Antimony Corporation filed a Form 8-K to share that, on October 6, 2025, it issued a press release announcing the pricing of a registered direct offering.

Rhea-AI Filing Summary

United States Antimony Corporation filed a Form 8-K to share that, on October 6, 2025, it issued a press release announcing the pricing of a registered direct offering. The company is using this current report to make the information broadly available under Regulation FD, which is designed to ensure that all investors receive important company information at the same time.

The press release, dated October 6, 2025, is included as an exhibit to the report and is incorporated by reference. The company also clarifies that this disclosure is being treated as “furnished” rather than “filed,” which limits how it is used for certain legal liability purposes under the securities laws.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did United States Antimony Corporation (UAMY) disclose in this Form 8-K?

The company disclosed that it issued a press release on October 6, 2025 announcing the pricing of a registered direct offering, and furnished that press release as an exhibit.

What is the main purpose of this UAMY Form 8-K filing?

The main purpose is to provide a Regulation FD disclosure by making public the press release that announced the pricing of a registered direct offering.

Which item of Form 8-K does United States Antimony Corporation use for this disclosure?

The company uses Item 7.01, Regulation FD Disclosure, to report the press release about the pricing of a registered direct offering.

How is the press release about the registered direct offering treated under the securities laws?

The press release attached as Exhibit 99.1 is treated as information that is "furnished" under Item 7.01, not "filed" under Section 18 of the Securities Exchange Act of 1934.

What exhibit is included with this UAMY Form 8-K filing?

The filing includes Exhibit 99.1, which is a press release dated October 6, 2025 describing the pricing of a registered direct offering.

Who signed the Form 8-K for United States Antimony Corporation?

The report was signed on behalf of the company by Richard R. Isaak, who is the Senior Vice President and Chief Financial Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/06/2025 - 09:32 AM Learn about SEC filing dates

0000101538false00001015382025-10-062025-10-06iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported) October 6, 2025

UNITED STATES ANTIMONY CORPORATION

(Exact name of registrant as specified in its charter)

Texas		001-08675		81-0305822
(State or other jurisdiction of incorporation)		(Commission File No.)		(IRS Employer Identification Number)

4438 W. Lovers Lane, Unit 100, Dallas, TX		75209
(Address of principal executive officers)		(Zip Code)

Registrant’s telephone number, including area code: (406) 606-4117

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		UAMY		NYSE American
Common Stock, $0.01 par value		UAMY		NYSE Texas

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure

On October 6, 2025, the Company issued a press release announcing the pricing of a registered direct offering. The press release is furnished as exhibit 7.01 and incorporated by reference herein.

The information furnished under this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.  This Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press Release, dated October 6, 2025

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	UNITED STATES ANTIMONY CORPORATION
Dated: October 6, 2025	By:	Richard R. Isaak
		Richard R. Isaak
		SVP, Chief Financial Officer

3